SEARCH

SEARCH BY CITATION

References

  • 1
    Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt E, Cusi K, et al. The diagnosis and management of nonalcoholic fatty liver disease. Developed on behalf of the American Association for the Study of Liver Disease (AASLD), American College of Gastroenterology (ACG), and American Gastroenterology Association (AGA). Hepatology 2012; 55: 2005-2023.
  • 2
    Musso G, Gambino R, Cassader M, Pagano G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 2011; 43: 617-649.
  • 3
    Lazo M, Hernaez R, Bonekamp S, Kamel IR, Brancati FL, Guallar E, et al. Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. BMJ 2011; 343: d6891.
  • 4
    Charlton MR, Burns JM, Pedersen RA, Watt KD, Heimbach JK, Dierkhising RA. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology 2011; 141: 1249-1253.
  • 5
    Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, et al. The natural history of nonalcoholic fatty liver disease; a population-based cohort study. Gastroenterology 2005; 129: 113-121.
  • 6
    Dunn W, Xu R, Wingard DL, Rogers C, Angulo P, Younossi ZM, et al. Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Am J Gastroenterol 2008; 103: 2263-2271.
    Direct Link:
  • 7
    Ong JP, Pitts A, Younossi ZM. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. J Hepatol 2008; 48: 608-612.
  • 8
    Ruhl CE, Everhart JE. Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population. Gastroenterology 2009; 136: 477-485.
  • 9
    Stepanova M, Younossi Z. Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US. Clin Gastroenterol Hepatol 2012; 10: 646-650.